Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus

Cell Biochemistry and Function

Volumn 25, Issue 6, 2007, Pages 673-680

  Briede, J ^a   Stivrina, M ^a   Stoldere, Dz ^a   Vigante, B ^a   Duburs, G ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

Blood glucose; Cerebrocrast; Cytokines; Serum insulin

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; CEREBROCRAST; GLUCOSE; GLUCOSE TRANSPORTER; IMMUNOREACTIVE INSULIN; INSULIN; INSULIN RECEPTOR; STREPTOZOCIN; 2,6 DIMETHYL 3,5 BIS(2' PROPOXYETHOXYCARBONYL) 4 (2'' DIFLUOROMETHOXYPHENYL) 1,4 DIHYDROPYRIDINE; 2,6-DIMETHYL-3,5-BIS(2'-PROPOXYETHOXYCARBONYL)-4-(2''-DIFLUOROMETHOXYPHENYL)-1,4-DIHYDROPYRIDINE; DIHYDROPYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL MEMBRANE; CELL STIMULATION; CONTROLLED STUDY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; EXPERIMENTAL DIABETES MELLITUS; MALE; METABOLISM; TIME;

RATTUS;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; INSULIN; MALE; RATS; STREPTOZOCIN; TIME FACTORS;

EID: 38449086584     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1372     Document Type: Article

References (50)

1. Iwashashi I, Itoh N, Yamagata K, et al. Molecular mechanisms of pancreatic beta-cell destruction in autoimmune diabetes: potential targets for preventive therapy. Cytokines Cell Mol Ther 1998; 4: 45-51.
2. Hussain MJ, Peakman M, Gallati H, et al. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 1996; 39: 60-69.
3. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998; 55: 1139-1149.
4. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 1996; 39: 1005-1029.
5. Davi G, Chiarelli F, Santilli F, et al. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation 2003; 107: 3199-3203.
6. Kim HJ, Higashimori T, Park SY, et al. Differential effects of interleukin-6 and-10 on skeletal muscle and liver insulin action in vivo. Diabetes 2004; 53: 1060-1067.
7. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334.
8. Hotamisligil GS, Shargil NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
9. Choquet-Kastylevsky G, Descotes J. Popliteal lymph node responses to acetone and ethanol differ from those induced by streptozotocin. Arch Toxicol 2004; 78: 649-654.
10. Robbins MJ, Sharp RA, Slonim AE, et al. Protection against streptozotocin-induced diabetes by superoxide dismutase. Diabetologia 1980; 18: 55-58.
11. Haluzik M, Nedvidkova J. The role of nitric oxide in the development of streptozotocin-induced diabetes mellitus: experimental and clinical implications. Physiol Res 2000; 49: (Suppl. 1): S37-S42.
12. 2 as mediator for DNA fragmentation. Diabetes 1991; 40: 1141-1145.
13. Scarim AL, Heitmeier MR, Corbett JA. Heat shock inhibits cytokine-induced nitric oxide synthase expression by rat and human islets. Endocrinology 1998; 139: 5050-5057.
14. Lakey JR, Suarez-Pinzon WL, Strynadka K, et al. Peroxynitrite is a mediator of cytokine-induced destruction of human pancreatic islet beta cells. Lab Invest 2001; 81: 1683-1692.
15. Radi R, Cassina A, Hodara R. Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem 2002; 383: 401-409.
16. Corbett JA, McDaniel ML. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exper Med 1995; 181: 559-568.
17. Delaney CA, Pavlovic D, Hoorens A, et al. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islets cells. Endocrinology 1997; 138: 2610-2614.
18. Kullin M, Li Z, Hansen JB, et al. K (ATP) channel openers protect rat islets against the toxic effect of streptozotocin. Diabetes 2000; 49: 1131-1136.
19. Sandler S, Bendtzen K, Borg LAH, et al. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1β indicate a perturbation in the mitochondrial function. Endocrinology 1989; 124: 1492-1501.
20. Mellado-Gil JM, Aguilar-Diosdado M. High glucose potentiates cytokine- and streptozotocin-induced apoptosis of rat islet cells: effect on apoptosis-related genes. J Endocrinology 2004; 183: 155-162.
21. Maedler K, Sergejeev P, Ris F, et al. Glucose-induced B cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002; 110: 851-860.
22. Devaraj S, Venugopal SK, Singh U, et al. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase C-α, and β. Diabetes 2005; 54: 85-91.
23. Klover PJ, Clementi AH, Mooney RA. Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 2005; 146: 3417-3427.
24. Tsigos C, Papanicolaou DA, Kyrou I, et al. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metabolism 1997; 82: 4167-4170.
25. Matsumori A, Ono K, Nishio R, et al. Amlodipine inhibits the production of cytokines induced by ouabain. Cytokine 2000; 12: 294-297.
26. Yuan Z, Kishimoto C, Shioji K. Beneficial effects of low-dose benidipine in acute autoimmune myocarditis: suppressive effects on inflammatory cytokines inducible nitric oxide synthase. Cir J 2003; 67: 545-550.
27. Hishikawa K, Luscher TF. Felodipine inhibits free-radical production by cytokines and glucose in human smooth muscle cells. Hypertension 1998; 32: 1011-1015.
28. Klegeris A, Liutkevicius E, Mikalauskiene G, et al. Antiinflammatory effects of cerebrocrast in a model of rat paw edema and on mononuclear THP-1 cells. Eur J Pharmacol 2002; 441: 203-208.
29. Briede J, Daija D, Stivrina M, et al. Effect of cerebrocrast on the lymphocyte blast transformation activity in normal and streptozotocin- induced diabetic rats. Cell Biochem Funct 1999; 17: 89-96.
30. Matsumori A, Nunokawa Y, Sasayama S. Nifedipine inhibits activation of transcription factor NF-kappa B. Life Sci 2000; 67: 2655-2661.
31. Joost HG, Beckmann J. On the relation of glucose and insulin secretion in the fasting state. Metabolism 1980; 29(1): 23-27.
32. Iwashima Y, Kondoh-Abiko A, Seino S, et al. Reduced levels of messenger ribonucleic acid for calcium channel, glucose transporter-2, and glucokinase are associated with alterations in insulin secretion in fasted rats. Endocrinology 1994; 135: 1010-1017.
33. Maeda T, Sakita R, Kaihatsu T, et al. Sustained hyperglycemia and insulin resistance induced by dietary restriction. Biol Pharm Bull 2001; 24: 950-953.
34. Streeper RS, Svitek CA, Chapman SC. et al. A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin. J Biol Chem 1997; 272: 11698-11701.
35. Lange AJ, Argaud D, el-Maghrabi MR, et al. Isolation of a cDNA for the catalytic subunit of rat liver glucose-6-phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP Biochem Biophys Res Commun 1994; 201: 302-309.
36. Briede J, Daija D, Bisenieks E, et al. Effect of some 1,4-dihydropyridine Ca antagonists on the blast transformation of rat spleen lymphocytes. Cell Biochem Funct 1999; 17: 97-105.
37. Briede J, Stivriņa M, Stoldere Dz, et al. Effect of new and known 1,4-dihydropiridine derivatives on blood glucose levels in normal and streptozotocin-induced diabetic rats. Cell Biochem Funct 2004; 22: 219-224.
38. Andreis PG, Neri G, Belloni AS, et al. Interleukin-1β enhances corticosterone secretion by acting directly on the rat adrenal gland. Endocrinology 1991; 129: 53-57.
39. Naitoh Y, Fukata J, Tominaga T, et al. Interleukin-6 stimulates the secretion of adrenocorticotrophic hormone in conscious, free-moving rats. Biochem Biophys Res Commun 1988; 155: 1459-1463.
40. Cupps TR, Gerrard TL, Falkoff RJ, et al. Effect of in vitro corticosteroids on B cell activation, proliferation and differentiation. J Clin Invest 1985; 75: 754.
41. Gillis S, Crabtree G, Smith K. Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect of mitogen-induced lymphocyte proliferation. J Immunol 1979; 123: 1624.
42. Daynes RA, Araneo BA. Contrasting effects of glucocorticoids on the capacity of T cells to produce growth factors interleukins-2 and interleukins-4. Eur J Immunol 1989; 19: 2319-2325.
43. Zubiaga AM, Munoz E, Huber BT. IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. J Immunol 1992; 149: 107-112.
44. Nieto MA, Gonzalez F, Gambon F, et al. Apoptosis in human thymocytes after treatment with glucocorticoids. Clin Exp Immunol 1992; 88: 341-344.
45. Dimitriadis G, Leighton B, Parry-Billings M, et al. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J 1997; 321: 707-712.
46. Burkart V, Zielasek J, Kantwerk-Funke G, et al. Low dose streptozotocin-induced diabetes in mice: reduced IL-2 production and modulation of streptozotocin-induced hyperglycemia by IL-2. Int J Immunopharmacol 1992; 14: 1037-1044.
47. Zipris D, Lazarus AH, Crow AR, et al. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune non-obese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis. J Immunol 1991; 146: 3763-3771.
48. Harnish MJ, Lange T, Dimitrov S, et al. Differential regulation of human blood glucose level by interleukin-2 and-6. Exp Clin Endocrinol Diabetes 2005; 113: 43-48.
49. Briede J, Stivrina M, Heidemanis K, et al. Effect of cerebrocrast on glucose uptake in heart, brain of rats and on glucose transport in isolated human erythrocytes. Fundamental & Clin Pharmacol 1999; 13(Suppl. 1): 170.
50. Scarim AL, Arnush M, Hill JR, et al. Evidence for the presence of type I IL-1 receptors on beta-cells of islets of Langerhans. Biochim Biophys Acta 1997; 1361: 313-320.